2012
DOI: 10.3233/rnn-2012-110209
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion

Abstract: Purpose Stroke disability stems from insufficient neurorepair mechanisms. Improvement of functions has been achieved through rehabilitation or therapeutic agents. Therefore, we combined exercise with a neurovascular protective agent, S-nitrosoglutathione (GSNO), to accelerate functional recovery. Methods Stroke was induced by middle cerebral artery occlusion for 60 min followed by reperfusion in adult male rats. Animals were treated with vehicle (IR group), GSNO (0.25 mg/kg, GSNO group), rotarod exercise (EX… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
46
0
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 39 publications
(48 citation statements)
references
References 45 publications
(84 reference statements)
1
46
0
1
Order By: Relevance
“…This disturbed NO metabolome in TBI is supported by previous studies from our laboratory in TBI (Khan et al, 2011) and stroke (Khan et al, 2012; Khan et al, 2015b) and the current results, which show increased enzymatic nNOS activity (Fig 1B) and sustained high levels of peroxynitrite for a prolonged periods (Figs 2D–d and 4B–b). We investigated the mechanisms of the efficacy of GSNO for TBI therapy because it corrected not only the disturbed NO metabolome (Fig 1) and NO/S-nitrosylation-based cellular functions (Khan et al, 2005; Khan et al, 2011; Khan et al, 2015a; Sakakima et al, 2012) but also provided neuroprotection and improved neurological functions, as shown in Fig 5.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…This disturbed NO metabolome in TBI is supported by previous studies from our laboratory in TBI (Khan et al, 2011) and stroke (Khan et al, 2012; Khan et al, 2015b) and the current results, which show increased enzymatic nNOS activity (Fig 1B) and sustained high levels of peroxynitrite for a prolonged periods (Figs 2D–d and 4B–b). We investigated the mechanisms of the efficacy of GSNO for TBI therapy because it corrected not only the disturbed NO metabolome (Fig 1) and NO/S-nitrosylation-based cellular functions (Khan et al, 2005; Khan et al, 2011; Khan et al, 2015a; Sakakima et al, 2012) but also provided neuroprotection and improved neurological functions, as shown in Fig 5.…”
Section: Discussionmentioning
confidence: 99%
“…The NeuN immunostaining indicates number of neurons. Paraffin-embedded brain sections from the formalin-fixed brain tissues, processed at 14 days after CCI, were used to stain with Nissl and the staining was performed according to classical histology methods as previously described from our laboratory (Khan et al, 2015a; Sakakima et al, 2012). Cells that contained Nissl substance were considered to be viable neurons.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Experimental rehabilitative therapies may influence synaptogenesis, neurogenesis, and neuron and glial responses in addition to functional recovery [6, 7]. Although positive effects of skilled training as a rehabilitative modality have been reported, neurobiological mechanisms that support motor and functional recovery are not completely elucidated [8, 9].…”
Section: Introductionmentioning
confidence: 99%